Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
The declaration increased AOM use and, to a lesser extent, MBS use. Semaglutide approval increased AOM use but had no impact on MBS use.
Authors
- Christopher Boyer (ORCID: https://orcid.org/0000-0002-1101-2045)
- Phuc Le (ORCID: https://orcid.org/0000-0003-4788-773X)
- Yihua Yue (ORCID: https://orcid.org/0000-0001-5474-5348)
- Hamlet Gasoyan (ORCID: https://orcid.org/0000-0002-1627-9777)
- Ha T. Tran (ORCID: https://orcid.org/0000-0003-3064-0984)
- Olajide Adekunle
- Dev Yash Gupta
- Michael B Rothberg
Institutions
- Cleveland Clinic (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Chester County Historical Society (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Obesity
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1002/oby.70151
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00